Xenon Pharmaceuticals Inc. XENE
NASDAQ · United States · Health Technology
$37.19-0.06 (-0.16%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -1.11 | -1.14 | +2.8% | $0 | -100.0% | -1.5%$64.30→$63.36 |
| Q1 2026 | 2026-05-07 | -1.17 | -1.20 | +2.5% | — | — | -3.7%$58.59→$56.44 |
| Q4 2025 | 2026-02-26 | -1.31 | -1.21 | -8.3% | — | — | -3.0%$44.58→$43.23 |
| Q3 2025 | 2025-11-03 | -1.15 | -1.16 | +0.9% | — | — | -6.8%$41.92→$39.09 |
| Q2 2025 | 2025-08-11 | -1.07 | -0.99 | -8.1% | — | — | — |
| Q1 2025 | 2025-05-12 | -0.83 | -0.90 | +7.8% | — | — | — |
| Q4 2024 | 2025-02-27 | -0.84 | -0.84 | 0.0% | — | — | — |
| Q3 2024 | 2024-11-12 | -0.81 | -0.79 | -2.5% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.